Emerson (EMR) PT Raised to $155 at DA Davidson, Neutral Rating Maintained

DA Davidson analyst Chris Dankert raised the price target on Emerson (NYSE: EMR) to $155.00 (from $145.00) while maintaining a Neutral rating.

The analyst commented, "We are reiterating our ‘NEUTRAL’ rating on EMR and raising our price target to $155 (+$10 vs. prior), reflecting modestly higher estimates for FY27 and increasing conviction in EMR’s advantaged position within the current upcycle. Our PT reflects 18.9x our FY28 EPS forecast of $8.20 vs. a 5-yr median of 19.4x, as our model suggests achievement of EMR’s 2025 analyst day targets are well within reach. EMR enjoys significant exposure to secular tailwinds including increasing power gen demands, LNG investment, and near/re-shoring, partially offset by project delay risk and trade/conflict headwinds."

You May Also Be Interested In

• JBS SA (JBS) PT Raised to $17.50 at UBS
• BMO Capital Reiterates Outperform Rating on ServiceTitan (TTAN)
• TD Cowen on Veeva Systems (VEEV): 'We Expect Improving Environment To Drive F2Q Beat'